Assenagon Asset Management S.A. Alnylam Pharmaceuticals, Inc. Transaction History
Assenagon Asset Management S.A.
- $60.5 Billion
- Q2 2025
A detailed history of Assenagon Asset Management S.A. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 17,686 shares of ALNY stock, worth $5.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,686
Previous 6,405
176.13%
Holding current value
$5.8 Million
Previous $1.73 Million
233.55%
% of portfolio
0.01%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ALNY
# of Institutions
722Shares Held
111MCall Options Held
978KPut Options Held
881K-
Capital World Investors Los Angeles, CA16.7MShares$5.49 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$4.28 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$3.13 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.35 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.45 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $40.4B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...